223 related articles for article (PubMed ID: 32523136)
1. Impact of COVID-19 on reperfusion strategies for acute coronary syndromes.
Torres-Escobar G; González-Pacheco H; Cruz JLB; Arias-Mendoza A; Araiza-Garaygordobil D
Arch Cardiol Mex; 2020; 90(Supl):62-66. PubMed ID: 32523136
[TBL] [Abstract][Full Text] [Related]
2. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
Bainey KR; Bates ER; Armstrong PW
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038
[No Abstract] [Full Text] [Related]
3. Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic.
Wang N; Zhang M; Su H; Huang Z; Lin Y; Zhang M
J Int Med Res; 2020 Oct; 48(10):300060520966151. PubMed ID: 33108941
[TBL] [Abstract][Full Text] [Related]
4. Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.
Butala NM; Patel NK; Chhatwal J; Vahdat V; Pomerantsev EV; Albaghdadi M; Sakhuja R; Rosenzweig A; Elmariah S
Circ Cardiovasc Interv; 2020 Nov; 13(11):e010027. PubMed ID: 33167699
[TBL] [Abstract][Full Text] [Related]
5. Care of acute coronary syndromes during the health contingency due to a SARS-CoV-2 outbreak.
Piña-Reyna Y; García-Rincón A; Ortiz-Fernández P PH; Alcocer-Gamba MA; Gutiérrez-Fajardo P; Merino-Rajme JA; Reyes-Terán G
Arch Cardiol Mex; 2020; 90(Supl):33-35. PubMed ID: 32523135
[TBL] [Abstract][Full Text] [Related]
6. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
[No Abstract] [Full Text] [Related]
7. Will the hidden specter of acute coronary syndrome (ACS) and ST-segment elevation myocardial infarction (STEMI) emerge from the avalanche of COVID-19?
Kapoor A; Yadav R
Indian Heart J; 2020; 72(3):192-193. PubMed ID: 32768020
[TBL] [Abstract][Full Text] [Related]
8. [Impact of the COVID-19 pandemic on admissions for acute coronary syndrome: review of the literature and single-center experience].
Vecchio S; Fileti L; Reggi A; Moschini C; Lorenzetti S; Rubboli A
G Ital Cardiol (Rome); 2020 Jul; 21(7):502-508. PubMed ID: 32555565
[TBL] [Abstract][Full Text] [Related]
9. Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.
Xiang D; Xiang X; Zhang W; Yi S; Zhang J; Gu X; Xu Y; Huang K; Su X; Yu B; Wang Y; Fang W; Huo Y; Ge J
J Am Coll Cardiol; 2020 Sep; 76(11):1318-1324. PubMed ID: 32828614
[TBL] [Abstract][Full Text] [Related]
10. The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
Roffi M; Guagliumi G; Ibanez B
Circulation; 2020 Jun; 141(24):1951-1953. PubMed ID: 32315205
[No Abstract] [Full Text] [Related]
11. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
Kirtane AJ; Bangalore S
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
[No Abstract] [Full Text] [Related]
12. Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Sudhakar D; Jneid H; Lakkis N; Kayani WT
Am J Cardiol; 2020 Nov; 134():158. PubMed ID: 32841613
[No Abstract] [Full Text] [Related]
13. Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak.
Ferlini M; Andreassi A; Carugo S; Cuccia C; Bianchini B; Castiglioni B; D' Urbano M; Guagliumi G; Lettieri C; Lettino M; Marenzi G; Metra M; Migliori M; Montorfano M; Oliva F; Savonitto S; Seregni R; Visconti LO
Int J Cardiol; 2020 Aug; 312():24-26. PubMed ID: 32339543
[No Abstract] [Full Text] [Related]
14. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
[TBL] [Abstract][Full Text] [Related]
15. In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic.
Huang B; Xu C; Liu H; Deng W; Yang Z; Wan J; Yan H; Cao G; Chen J; Jiang H
J Cardiovasc Pharmacol; 2020 Nov; 76(5):540-548. PubMed ID: 33170591
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.
Hamadeh A; Aldujeli A; Briedis K; Tecson KM; Sanz-Sánchez J; Al Dujeili M; Al-Obeidi A; Diez JL; Žaliūnas R; Stoler RC; McCullough PA
Am J Cardiol; 2020 Sep; 131():1-6. PubMed ID: 32732010
[TBL] [Abstract][Full Text] [Related]
17. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
Li YH; Huang WC; Hwang JJ;
Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
[No Abstract] [Full Text] [Related]
18. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19.
Setia G; Tyler J; Kwan A; Faguet J; Sharma S; Singh S; Azarbal B; Tompkins R; Chinchilla D; Ghandehari S
Rev Cardiovasc Med; 2020 Jun; 21(2):289-295. PubMed ID: 32706216
[TBL] [Abstract][Full Text] [Related]
19. Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon.
Vlachakis PK; Tentolouris A; Kanakakis I
J Thromb Thrombolysis; 2020 Nov; 50(4):809-813. PubMed ID: 32734526
[TBL] [Abstract][Full Text] [Related]
20. Decreases in cardiac catheter laboratory workload during the COVID-19 level 4 lockdown in New Zealand.
Elliott JM; Crozier IG
Intern Med J; 2020 Aug; 50(8):1000-1003. PubMed ID: 32881225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
